Wilms' tumor 1-KTS isoforms induce p53-independent apoptosis that can be partially rescued by expression of the epidermal growth factor receptor or the insulin receptor

Cancer Research

Volumn 57, Issue 7, 1997, Pages 1353-1363

  Menke, Aswin L ^a   Shvarts, Avi ^a   Riteco, Nicole ^a   Van Ham, Reinier C A ^a   Van der Eb, Alex J ^a   Jochemsen, Aart G ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; INSULIN RECEPTOR; PROTEIN P53; TRANSCRIPTION FACTOR; ZINC FINGER PROTEIN;

ALTERNATIVE RNA SPLICING; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEPHROBLASTOMA; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; DNA-BINDING PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; LIVER NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, INSULIN; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; WT1 PROTEINS;

EID: 0030978224     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. Hastie, N. D. The genetics of Wilms' tumor: a case of disrupted development (Review). Annu. Rev. Genet., 28: 523-558, 1994.
2. Call, K. M., Glaser, T., Ito, C. Y., Buckler, A. J., Pelletier, J., Haber, D. A., Rose, E. A., Krai, A., Yeger, H., Lewis, W. H., Jones, C., and Housman, D. E. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell, 60: 509-520, 1990.
3. Gessler, M., Konig, A., and Bruns, G. A. The genomic organization and expression of the WT1 gene. Genomics, 12: 807-813, 1992.
4. Haber, D. A., Sohn, R. L., Buckler, A. J., Pelletier, J., Call, K. M., and Housman, D. E. Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc. Natl. Acad. Sci. USA, 88: 9618-9622, 1991.
5. Bickmore, W. A., Oghene, K., Little, M. H., Seawright, A., van Heyningen, V., and Hastie, N. D. Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript. Science (Washington DC), 257: 235-237, 1992.
6. Drummond, I. A., Rupprecht, H. D., Rohwer-Nutter, P., Lopez- Guisa, J. M., Madden, S. L., Rauscher, F. J., III, and Sukhatme, V. P. DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1. Mol. Cell. Biol., 14: 3800-3809, 1994.
7. Madden, S. L., Cook, D. M., Morris, J. F., Gashler, A., Sukhatme, V. P., and Rauscher, F. J., III. Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science (Washington DC), 253: 1550-1553, 1991.
8. Rauscher, F. J., Morris, J. F., Tournay, O. E., Cook, D. M., and Curran, T. Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science (Washington DC), 250: 1259-1262, 1990.
9. Rupprecht, H. D., Drummond, I. A., Madden, S. L., Rauscher, F. J., III, and Sukhatme, V. P. The Wilms' tumor suppressor gene WT1 is negatively autoregulated. J. Biol. Chem., 269: 6198-6206, 1994.
10. Wang, Z. Y., Qiu, Q. Q., Huang, J., Gurrieri, M., and Deuel, T. F. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways. Oncogene, 10: 415-422, 1995.
11. Larsson, S. H., Charlieu, J. P., Miyagawa, K., Engelkamp, D., Rassoulzadegan, M., Ross, A., Cuzin, F., van Heyningen, V., and Hastie, N. D. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell, 81: 391-401, 1995.
12. Menke, A. L., Riteco, N., Van Ham, R. C. A., De Bruyne, C., Rauscher, F. J., III, Van der Eb, A. J., and Jochemsen, A. G. Wilms' tumor 1 splice variants have opposite effects on the tumorigenieity of adenovirus-transformed baby-rat kidney cells. Oncogene, 12: 537-546, 1996.
13. Menke, A. L., Van Ham, R. C. A., Sonneveld, E., Shvarts, A., Stanbridge, E. J., Miyagawa, K., Van der Eb, A. J., and Jochemsen, A. G. Human chromosome 11 suppresses the tumorigenicity of adenovirus transformed baby rat kidney cells: involvement of the Wilms' tumor 1 gene. Int. J. Cancer, 63: 76-85, 1995.
14. Park, S., Tomlinson, G., Nisen, P., and Haber, D. A. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor. Cancer Res., 53: 4757-4760, 1993.
15. Pelletier, J., Schalling, M., Buckler, A. J., Rogers, A., Haber, D. A., and Housman, D. Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes Dev., 5: 1345-1356, 1991.
16. Pritchard-Jones, K., Fleming, S., Davidson, D., Bickmore, W., Porteous, D., Gosden, C., Bard, J., Buckler, A., Pelletier, J., Housman, D, Van Heyningen, V., and Hastie, N. The candidate Wilms' tumour gene is involved in genitourinary development. Nature (Lond.), 346: 194-197, 1990.
17. Zhou, J., Rauscher, F. J., III, and Bondy, C. Wilms' tumor (WT1) gene expression in rat decidual differentiation. Differentiation, 54: 109-114, 1993.
18. Pritchard-Jones, K., and Fleming, S. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis. Oncogene, 6: 2211-2220, 1991.
19. Kerr, J. F. R, Winterford, C. M., and Harmon, B. V. Apoptosis: its significance in cancer and cancer therapy. Cancer (Phila.), 73: 2013-2026, 1994.
20. Coles, H. S. R., Burne, J. F., and Raff, M. C. Large scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development (Camb.), 118: 777-784, 1993.
21. Englert, C., Hou, X., Maheswaran, S., Bennett, P., Ngwu, C., Re, G. G., Garvin, A. J., Rosner, M. R., and Haber, D. A. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J., 14: 4662-4675, 1995.
22. Maheswaran, S., Englert, C., Bennett, P., Heinrich, G., and Haber, D. A. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Dev., 9: 2143-2156, 1995.
23. Kreidberg, J. A., Sariola, H., Loring, J. M., Maeda, M., Pelletier, J., Housman, D., and Jaenisch, R. WT-1 is required for early kidney development. Cell, 74: 679-691, 1993.
24. Aden, D. P., Fogel, A., Plotkin, S., Damjanov, I., and Knowles, B. B. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature (Lond.), 252: 615-616, 1979.
25. Koury, M. J., Koury, S. T., Bondurant, M. C., and Graber, S. E. Correlation of the molecular and anatomical aspects of renal erythropoietin production. Contrib. Nephrol., 76: 24-29; discussion, 30-32, 1989.
26. Zhuang, S., Shvarts, A., Jochemsen, A. G., Van Oorschot, A. A. A. M., Van der Eb, A. J., and Noteborn, M. H. M. Differential sensitivity for Ad5 E1B-21 kD and Bcl-2 proteins of apoptin-induced versus p53-induced apoptosis. Carcinogenesis (Lond.), 16: 2939-2944, 1995.
27. Puisieux, A., Galvin, K., Troalen, F., Bressac, B., Marcais, C., Galun, E., Ponchel, F., Yakicier, C., Ji, J., and Ozturk, M. Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines. FASEB J., 7: 1407-1413, 1993.
28. Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. V., and Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science (Washington DC), 249: 912-915, 1990.
29. Steegenga, W. T., Van Laar, T., Shvarts, A., Terleth, C., Van der Eb, A. J., and Jochemsen, A. G. Distinct modulation of p53 activity in transcription and cell-cycle regulation by the large (54 kDa) and small (21 kDa) adenovirus E1B proteins. Virology, 212: 543-554, 1995.
30. Takayama, S., Sato, T., Krajewski, S., Kochel, K., Irie, S., Millan, J. A., and Reed, J. C. Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell, 80: 279-284, 1995.
31. Takebe, Y., Seiki, M., Fujisawa, J. I., Hoy, P., Yokota, K., Arai, K-I., Yoshida, M., and Arai, N. SRα promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol., 8: 466-472, 1988.
32. Riedel, H., Dull, T. J., Schlessinger, J., and Ullrich, A. A chimeric receptor allows insulin to stimulate tyrosine kinase activity of epidermal growth factor receptor. Nature (Lond.), 324: 68-70, 1986.
33. Livneh, E., Prywes, R., Kashles, Q., Reiss, N., Sasson, I., Mory, Y., Ullrich, A., and Schlessinger, J. Reconstitution of human epidermal growth factor receptors and its deletion mutants in cultured hamster cells. J. Biol. Chem., 261: 12490-12497, 1986.
34. Morris, J. F., Madden, S. L., Tournay, O. E., Cook, D. M., Sukhatme, V. P., and Rauscher, F. J. Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus. Oncogene, 6: 2339-2348, 1991.
35. Van der Eb, A. J., and Graham, F. L. Assay of transforming activity of human tumor virus DMA. Methods Enzymol., 65: 826-839, 1980.
36. Gurney, E. G., Harrison, R. O., and Fenno, J. Monoclonal antibodies against simian virus 40 T antigens: evidence for distinct subclones of large T antigen and for similarities among nonviral T antigens. J. Virol., 34: 752-763, 1980.
37. Zantema, A., Fransen, J. A., Olivier, A. D., Ramaekers, F. C., Vooijs, G. P., Deleys, B., and Van der Eb, A. J. Localization of the E1B proteins of adenovirus 5 in transformed cells, as revealed by interaction with monoclonal antibodies. Virology, 142: 44-58, 1985.
38. Bradford, M. A rapid and sensitive method for the quantification of microgram quantities of protein, utilizing the principle of protein dye-binding. Anal. Biochem., 72: 248-254, 1976.
39. Telford, W. G., King, L. E., and Fraker, P. J. Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. Cytometry, 13: 137-143, 1992.
40. Zhuang, S., Shvarts, A., Van Ormondt, H., Jochemsen, A. G., Van der Eb, A. J., and Notebom, M. H. M. Apoptin, a protein derived from chicken anemia virus, induces p53-independent apoptosis in human osteosarcoma cells. Cancer Res., 55: 486-489, 1995.
41. Boe, R., Gjertsen, B. T., Vintermyr, O. K., Houge, G., Lanotte, M., and Doskeland, S. O. The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells. Exp. Cell Res., 195: 237-246, 1991.
42. Oberhammer, F. A., Pavelka, M., Sharma, S., Tiefenbacher, R., Purchio, A. F., Bursch, W., and Schulte-Hermann, R. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc. Natl. Acad. Sci. USA, 89: 5408-5412, 1992.
43. Collins, R. J., Harmon, B. V., Gobe, G. C., and Kerr, J. F. R. Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int. J. Radiat. Biol., 61: 451-453, 1992.
44. Ucker, D. S., Obermiller, P. S., Eckhart, W., Apgar, J. R., Berger, N. A., and Meyers, J. Genome digestion is a dispensable consequence of physiological cell death mediated by cytotoxic T lymphocytes. Mol. Cell. Biol., 12: 3060-3069, 1992.
45. Wu, Y., Fraizer, G. C., and Saunders, G. F. GATA-1 transactivates the WT1 hematopoietic specific enhancer. J. Biol. Chem., 270: 5944-5949, 1995,
46. Haber, D., Buckler, A., Glaser, T., Call, K., Sohn, R., Douglass, E., and Housman, D. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell, 61: 1257-1269, 1990.
47. Debbas, M., and White, E. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev., 7: 546-554, 1993.
48. Boyd, J. M., Malstrom, S., Subramanian, T., Venkatesh, L. K., Schaeper U., Elangovan, B., D'Sa-Eipper, C., and Chinnadurai, G. Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell, 79: 341-351, 1994.
49. Chiou, S-K., Tseng, C. C., Rao, L., and White, E. Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells. J. Virol., 65: 6553-6566, 1994.
50. Oltvai, Z. N., and Korsmeyer, S. J. Checkpoints of duelling dimers foil death wishes. Cell, 79: 189-192, 1994.
51. Caelles, C., Heimberg, A., and Karin, M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature (Lond.), 370: 220-223, 1993.
52. Sabattini, P., Chiou, S-K., Rao, L., and White, E. Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein. Mol. Cell. Biol., 15: 1060-1070, 1995.
53. Van Dijk, M. A., Van Schaik, F. M. A., Bootsma, H. J., Holthuizen, P., and Sussenbach, J. S. Initial characterization of the four promoters of the human insulin-like growth factor II gene. Mol. Cell. Endocrinol., 81: 81-94, 1991.
54. Hewitt, S. M., Hamada, S., McDonnell, T. J., Rauscher, F. J., III, and Saunders, G. F. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1. Cancer Res., 55: 5386-5389, 1995.
55. Miyashita, T., and Reed, J. C. Bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res., 52: 5407-5411, 1992.
56. Miyashita, T., and Reed, J. C. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood, 81: 151-157, 1993.
57. Selvakumaran, M., Lin, H. K., Sjin, R. T., Reed, J. C., Liebermann, D. A., and Hoffman, B. The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor β 1-induced apoptosis of myeioid leukemia cells. Mol. Cell. Biol., 14: 2352-2360, 1994.
58. Vaux, D. L., Cory, S., and Adams, J. M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (Lond.), 355: 440-442, 1988.
59. Zong, L., Sarafian, T., Kane, D. J., Charles, A. C., Mah, S. P., Edwards, R. H., and Bredesen, D. E. Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc. Natl. Acad. Sci. USA, 90: 4533-4537, 1993.
60. Frisch, S. M., and Francis, H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol., 124: 619-626, 1994.
61. Bates, R. C., Buret, A., Van Helden, D. F., Horion, M. A., and Burns, G. F. Apoptosis induced by inhibition of intercellular contact. J. Cell Biol., 125: 403-415, 1994.
62. Harrington, E. A., Bennett, M. R., Fanidi, A., and Evan, G. I. c-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J., 13: 3286-3295, 1994.
63. Koseki, C., Herzlinger, D., and Al-Awqati, Q. Apoptosis in metanephric development. J. Cell Biol., 119: 1327-1333, 1992.
64. Maheswaran, S., Park, S., Bernard, A., Morris, J. F., Rauscher, F. J., Hill, D. E., and Haber, D. A. Physical and functional interaction between WT1 and p53 proteins. Proc. Natl. Acad. Sci. USA, 90: 5100-5104, 1993.
65. Luo, X-N., Reddy, J. C., Yeyati, P. L., Idris, A. H., Hosono, S., Haber, D. A., Licht, J. D., and Atweh, G. F. The tumor suppressor gene WT1 inhibits ras-mediated transformation. Oncogene, 11: 743-750, 1995.
66. Can, B. I., Huang, T. H., Itakura, K., Noel, M., and Marceau, N. TGF β gene transcription in normal and neoplastic liver growth. J. Cell. Biochem., 39: 477-487, 1989.
67. Derynck, R., Goeddel, D. V., Ullrich, A., Gutterman, J. U., Williams, R. D., Bringman, T. S., and Berger, W. H. Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res., 47: 707-712, 1987.
68. Lin, J-K., and Chou, C-K. In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor β1. Cancer Res., 52: 385-388, 1992.
69. Ponchel, F., Puisieux, A., Tabone, E., Michot, J. P., Froschl, G., Morel, A. P., Frebourg, T., Fontaniere, B., Oberhammer, F., and Ozturk, M. Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity but has no effect on transforming growth factor β1-mediated apoptosis. Cancer Res., 54: 2064-2068, 1994.
70. Nakayama, K., Nakayama, K-I., Negishi, I., Kuida, K., Sawa, H., and Loh, D. Y. Targeted disruption of Bcl-2ab in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc. Natl. Acad. Sci. USA, 91: 3700-3704, 1994.
71. Craig, R. W. The Bcl-2 gene family. Cancer Biol., 6: 35-43, 1995.
72. Sato, T., Hanada, M., Bodrug, S., Irie, S., Iwama, N., Boise, L. H., Thompson, C. B., Golemis, E., Fong, L., Wang, H-G., and Reed, J. C. Interactions among members of the bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. USA, 91: 9238-9242, 1994.
73. Toniolo, D., Persico, M., and Alcalay, M. A "housekeeping" gene on the X chromosome encodes a protein similar to ubiquitin. Proc. Natl. Acad. Sci. USA, 85: 851-855, 1988.
74. Cortazzo, M., and Schor, N. F. Potentiation of enediyne-induced apoptosis and differentiation by Bcl-2. Cancer Res., 56: 1199-1203, 1996.
75. Kiefer, M. C., Brauer, M. J., Powers, V. C., Wu, J. J., Umansky, S. R., Tomei, L. D., and Barr, P. J. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature (Lond.), 374: 736-739, 1995.
76. Middleton, G., Nunez, G., and Davies, A. M. Bax promotes neuronal survival and antagonises the survival effects of neurotrophic factors. Development (Camb.), 122: 695-701, 1996.
77. Werner, H., Re, G. G., Drummond, I. A., Sukhatme, V. P., Rauscher, F. J., III, Sens, D. A., Garvin, A. J., LeRoith, D., and Roberts, C. T., Jr. Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the W1 Wilms tumor gene product. Proc. Natl. Acad. Sci. USA, 90: 5828-5832, 1993.
78. Werner, H., Shen-Orr, Z., Rauscher, F. J., III, Morris, J. F., Roberts, C. T., Jr., and LeRoith, D. Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression. Mol. Cell. Biol., 15: 3516-3522, 1995.
79. Resnicoff, M., Burgaud, J-L., Rotman, H. L., Abraham, D., and Baserga, R. Correlation between apoptosis, tumorigenesis and levels of insulin-like growth factor I receptors. Cancer Res., 55: 3739-3741, 1995.
80. Burgering, B. M. T., Medema, R. H., Maassen, J. A., Van de Wetering, M. L., Van der Eb, A. J., McCormick, F., and Bos, J. L. Insulin stimulation of gene expression mediated by p21ras activation. EMBO J., 10: 1103-1109, 1991.
81. Wang, Z-Y., Qiu, Q-Q., Enger, K. T., and Deuel, T. A second transcriptionally active DNA-binding site for Wilms tumor gene product, WT1. Proc. Natl. Acad. Sci. USA, 90: 8896-8900, 1993.
82. Boonstra, J., Rijken, P., Humbel, B., Cremers, F., Verkleij, A., and Van Bergen en Henegouwen, P. The epidermal growth factor. Cell Biol. Int., 19: 413-430, 1995.
83. Huang, R-P., Darland, T., Okamura, D., Mercola, D., and Adamson, E. D. Suppression of v-sis dependent transformation by the transcription factor Egr-1. Oncogene, 9: 1367-1377, 1994.
84. Rosen, O. M. After Insulin binds. Science (Washington DC), 237: 1452-1458, 1987.
85. Louard, R. J., Fryburg, D. A., Gelfand, R. A., and Barrett, E. J. Insulin sensitivity of protein and glucose metabolism in human forearm skeletal muscle. J. Clin. Invest., 90: 2348-2354, 1992.
86. Savil, J. Apoptosis and renal injury. Curr. Opin. Nephrol. Hypertens., 4: 263-269, 1995.